ABBV vs. NEM
ABBV (AbbVie Inc.) and NEM (Newmont Corporation) are both stocks. ABBV operates in Drug Manufacturers - General (Healthcare), while NEM operates in Gold (Basic Materials). Over the past 10 years, ABBV returned 19.10%/yr vs 13.80%/yr for NEM. At a 0.06 correlation, their price movements are largely independent.
Performance
ABBV vs. NEM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ABBV achieves a 1.30% return, which is significantly higher than NEM's 0.82% return. Over the past 10 years, ABBV has outperformed NEM with an annualized return of 19.10%, while NEM has yielded a comparatively lower 13.80% annualized return.
ABBV
- 1D
- 1.32%
- 1M
- 8.24%
- YTD
- 1.30%
- 6M
- 3.65%
- 1Y
- 23.06%
- 3Y*
- 22.39%
- 5Y*
- 18.94%
- 10Y*
- 19.10%
NEM
- 1D
- 2.71%
- 1M
- -7.88%
- YTD
- 0.82%
- 6M
- 2.58%
- 1Y
- 74.95%
- 3Y*
- 36.14%
- 5Y*
- 10.51%
- 10Y*
- 13.80%
ABBV vs. NEM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 1.30% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
NEM Newmont Corporation | 0.82% | 172.82% | -7.83% | -8.76% | -20.77% | 7.40% | 40.28% | 30.52% | -6.15% | 10.91% |
Correlation
The correlation between ABBV and NEM is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2013 | 0.06 |
Fundamentals
ABBV:
$2.05
NEM:
$6.34
ABBV:
110.96
NEM:
15.82
ABBV:
6.43
NEM:
4.83
ABBV:
$62.82B
NEM:
$17.23B
ABBV:
$46.15B
NEM:
$8.97B
ABBV:
$17.96B
NEM:
$13.78B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABBV vs. NEM — Risk / Return Rank
ABBV
NEM
ABBV vs. NEM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Newmont Corporation (NEM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ABBV | NEM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.81 | ||
| Sortino ratioReturn per unit of downside risk | -0.66 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.29 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | 1.29 | 2.78 | -1.49 |
| Martin ratioReturn relative to average drawdown | 2.88 | 7.58 | -4.71 |
Loading charts...
Drawdowns
ABBV vs. NEM - Drawdown Comparison
The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum NEM drawdown of -81.30%. Use the drawdown chart below to compare losses from any high point for ABBV and NEM.
Loading charts...
Drawdown Indicators
| ABBV | NEM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.09% | -81.30% | +36.21% |
Max Drawdown (1Y)Largest decline over 1 year | -17.32% | -29.39% | +12.07% |
Max Drawdown (3Y)Largest decline over 3 years | -20.74% | -36.57% | +15.83% |
Max Drawdown (5Y)Largest decline over 5 years | -21.92% | -62.40% | +40.48% |
Max Drawdown (10Y)Largest decline over 10 years | -45.09% | -62.40% | +17.31% |
Current DrawdownCurrent decline from peak | -4.60% | -23.71% | +19.11% |
Average DrawdownAverage peak-to-trough decline | -10.71% | -41.37% | +30.66% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.75% | 10.73% | -2.98% |
Volatility
ABBV vs. NEM - Volatility Comparison
The current volatility for AbbVie Inc. (ABBV) is 6.10%, while Newmont Corporation (NEM) has a volatility of 15.74%. This indicates that ABBV experiences smaller price fluctuations and is considered to be less risky than NEM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ABBV | NEM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.10% | 15.74% | -9.64% |
Volatility (6M)Calculated over the trailing 6-month period | 17.85% | 37.43% | -19.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.31% | 47.44% | -23.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.89% | 37.99% | -15.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.73% | 35.67% | -9.94% |
Dividends
ABBV vs. NEM - Dividend Comparison
ABBV's dividend yield for the trailing twelve months is around 2.96%, more than NEM's 1.02% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.96% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
NEM Newmont Corporation | 1.02% | 1.00% | 2.69% | 3.87% | 4.66% | 3.55% | 1.74% | 3.31% | 1.62% | 0.67% | 0.37% | 0.56% |
Financials
ABBV vs. NEM - Financials Comparison
This section allows you to compare key financial metrics between AbbVie Inc. and Newmont Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ABBV and NEM have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NEM has higher volatility (15.74%) compared to ABBV (6.10%). In terms of maximum drawdown, ABBV dropped -45.09% vs NEM's -81.30%.
NEM currently has the higher Sharpe Ratio (1.73 vs 0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ABBV and NEM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer